As head of the Translational Breast Cancer Genomics and Therapeutics Laboratory, Professor Sherene Loi's research interest is to translate interesting scientific findings into innovative treatment approaches that may ultimately improve the survival of breast cancer patients. To facilitate this, her laboratory uses genomic approaches to analyse breast cancer specimens to understand mechanisms of growth, immune evasion and progression. For patients, Prof. Loi's interest lies in clinical trials evaluating targeted agents against specific breast cancer molecular subtypes.
In the news
Prof. Sherene Loi awarded prestigious clinical research fellowship to advance breast cancer clinical trials at Peter Mac
Prof. Sherene Loi sheds new light on immunology of breast cancer at international conference